Join this Featured Workgroup!
Elite Investors

This group is for elite investors and traders that are dedicated to participating in an active community that wants to learn from each other, share their research, and work together to do deep analysis of securities. The moderator of this group taught securities analysis at UCLA and is dedicated to helping other investors improve their abilities.

In this private group, membership is restricted and regular contributions are required. Any member not contributing on a regular basis will be removed to make room for a new member.

In your application messsage, please share your background and what you can contribute to the group.



Company Overview and News

0
Is EEIAX a Strong Bond Fund Right Now?

2018-07-12 zacks
There are plenty of choices in the International Bond - Emerging category, but where should you start your research? Well, one fund that might be worth investigating is Eaton Vance Emerging Markets Local Income A (EEIAX - Free Report) . EEIAX carries a Zacks Mutual Fund Rank of 2 (Buy), which is based on nine forecasting factors like size, cost, and past performance.
LMT EV

0
EV / Eaton Vance Corp. EVC8K71118 (Current Report)

2018-07-11 sec.gov
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K
EV

1
AFGlobal ProposesTerms For $118 Million IPO

2018-07-10 seekingalpha
AFG Holdings has filed proposed terms for a U.S. IPO of its common stock and that of selling shareholders.
CG AA EV PCP

0
CEFs: Floating Rate Funds Finally Showing Signs Of What They Are Intended For

2018-07-09 seekingalpha
Floating rate notes are a variable rate coupon, generally tied to either LIBOR or the federal funds rate.
EVF FRA EFL BGT EV

1
AFGlobal Starts U.S. IPO Effort

2018-07-05 seekingalpha
AFGlobal (AFGL) intends to raise $100 million in a U.S. IPO of its common stock, according to an SEC registration statement.
CG AA EV PCP

1
Recent Distribution Cuts Among Closed-End Funds

2018-07-05 seekingalpha
The first business day of the month brings out the distribution notices for the next month.
BGX BST HYT TCRX FRA TCRD BGT TCRZ EV TSLF

0
Is EEIAX a Strong Bond Fund Right Now?

2018-07-03 zacks
International Bond - Emerging fund seekers should consider taking a look at Eaton Vance Emerging Markets Local Income A (EEIAX - Free Report) . EEIAX bears a Zacks Mutual Fund Rank of 2 (Buy), which is based on nine forecasting factors like size, cost, and past performance.
ABX EV ABX

57
Screening Closed End Funds

2018-07-02 seekingalpha
I consulted with some of Seeking Alpha's "best and brightest" CEF investors as a "Nominating Committee."
HD NFJ RFI BME CCL EPD CUK MORN EV FOF CII DIAX CUKPF ETV QQQX CCL DOW NIE EOS

2
A Muni Bond Fund With Double-Digit Total Return Potential

2018-07-02 seekingalpha
A small part of the investment scene involves muni bond funds that use leverage to enhance returns.
EIM EV

226
Trade War - 4 Strategies To Protect Your Portfolio

2018-06-29 seekingalpha
The outcome of current trade negotiations between the U.S. and several of its largest trade partners is uncertain.
FB VTIP TIP NFLX GOOG GLD EV IAU O87 GOOGL AAPL STIP

16
Delek US Holdings Quietly Positioned For Upside

2018-06-29 seekingalpha
Delek US Holdings is profiting from a confluence of factors: operational efficiencies, unusually good crude access, RIN waivers, and strong product markets.
DK CVI XOM ANDV MPC EV

2
CEF ETJ: May Be Defensive But Just Go For Treasury ETFs Instead

2018-06-25 seekingalpha
In a previous article, a few readers had asked my thoughts on ETJ as a defensive position for a volatile market.
IEF SHY EV

56
MLP Monthly Report: June 2018

2018-06-20 seekingalpha
The June MLP Monthly Report can be found here offering insights on MLP industry news, the asset class’s performance, yields, valuations, and fundamental drivers.
SNSR MLPA AND LIT CVI BFIT KMI.WS GXG SIL KRMA GXF EPD CHII EV ACTX CHIE GOEX KMI.PRA KMI FINX CHIX KMR CVB SRET BOTZ CATH GURX GURI ALUM MILN CJHIQ URA BHI LNGR COPX CVRR QQQC KRP GURU KMRFZ

280
CEF ETB: The Undervalued Eaton Vance Option Fund

2018-06-19 seekingalpha
ETB is currently at a slight premium, however, when looking at its 1-year z-score it is the cheapest of the Eaton Vance funds that utilize options for enhanced income.
ETB AMZN AAPL MSFT EV

32
Wealth management startup SigFig secures $50 mln round led by General Atlantic

2018-06-19 reuters
NEW YORK (Reuters) - SigFig, a San Francisco-based startup that provides wealth management technology to financial companies, has raised $50 million from investors, it said on Tuesday.
WFC WFCNP WFC.WS WFC.PRL WFC.PRJ EV WFC.PRT WFC.PRR WFC.PRQ WFC.PRP WFC.PRO UBS WFC.PRN UBS.PRDCL WFC.PRY WFC.PRX WFC.PRW WFC.PRV ULSGF

Related Articles

KTOV: Kitov Pharamceuticals Holdings Analysis and Research Report

33m - Asif

History and Development of the Company Kitov Pharma was incorporated under the laws of the State of Israel (under a previous name) on August 12, 1968 and its ordinary shares were originally listed for trading on the TASE in 1978. The company's ordinary shares are currently traded on the TASE under the symbol “KTOV”, and its ADSs and its public warrants are traded on NASDAQ under the symbols “KTOV” and “KTOVW”, respectively. In October 2012, the District Court in Lod, Israel approved the creditors arrangement in accordance with Section 350 of the Companies Law in order to effectuate the sale by Kitov Pharma (then known as Mainrom Line Logistics Ltd.) of all its activities, assets, rights, obligations and liabilities to a private company held by its then controlling shareholders, and all rights of Kitov Pharma’s creditors against it were extinguished. The sale was made pursuant to an arrangement between Kitov Pharma and its creditors. Following such sale and a related cash...

ATHX: Athersys Analysis and Research Report

2h - Asif

Overview and Recent Developments Athersys is an international biotechnology company that is focused primarily in the field of regenerative medicine. The company's MultiStem® cell therapy, a patented and proprietary allogeneic stem cell product, is its lead platform product and is currently in later-stage clinical development. The company's current clinical development programs are focused on treating neurological conditions, cardiovascular disease, inflammatory and immune disorders, certain pulmonary conditions and other conditions where the current standard of care is limited or inadequate for many patients, particularly in the critical care segment. Current Programs By applying its proprietary MultiStem cell therapy product, the company established therapeutic product development programs treating neurological conditions, cardiovascular disease, inflammatory and immune disorders, and other conditions. The company's programs in the clinical development stage include ...

CYTX: Cytori Therapeutics Analysis and Research Report

22h - Asif

General The company's objective is to build a profitable and growing specialty therapeutics company. To meet this objective, Cytori Therapeutics has acquired and are developing two technology platforms that hold promise for treating millions of patients and represent significant potential for increasing shareholder value. The company's current corporate activities fall substantially into advancing these platforms: Cytori Nanomedicine and Cytori Cell Therapy. The Cytori Nanomedicine platform features a versatile liposomal nanoparticle technology for drug encapsulation that has thus far provided the foundation to bring two promising drugs into mid/late stage clinical trials. Nanoparticle encapsulation is promising because it can help improve the delivery and metabolism of many drugs, thus potentially enhancing the therapeutic profile and patient benefits. The company's lead drug candidate, ATI-0918 is a generic version of pegylated liposomal encapsulated doxorubicin. Pegyl...

Silicon Investor Message Boards

This table lists all message boards related to EV / Eaton Vance Corp. on message board site Silicon Investor.

Formerly About Advanced Micro Devices vitamins herbs supplements longevity and aging
Gold Rush: Nevada Severe Weather and the Economic Impact
Books, Movies, Food, Wine, and Whatever Tesla EVs - TSLA
Television and Movies What Ever Happened To That Company?
Heart Attacks, Cancer and strokes. Preventative approaches A Review of TV Commercials: The Good, The Bad, u0026 The Ugly
CUSIP: 278265103